Heartflow (NASDAQ:HTFL) CFO Sells $33,406.68 in Stock

Heartflow, Inc. (NASDAQ:HTFL) CFO Vikram Verghese sold 668 shares of the firm’s stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $50.01, for a total value of $33,406.68. Following the transaction, the chief financial officer owned 179,528 shares of the company’s stock, valued at $8,978,195.28. The trade was a 0.37% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Vikram Verghese also recently made the following trade(s):

• On Monday, September 14th, Vikram Verghese sold 4,593 shares of Heartflow stock. The shares were sold at an average price of $50.24, for a total transaction of $230,752.32.
• On Friday, September 11th, Vikram Verghese sold 29,714 shares of Heartflow stock. The shares were sold at an average price of $50.06, for a total transaction of $1,487,482.84.
• On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The stock was sold at an average price of $50.03, for a total transaction of $332,199.20.
• On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The shares were sold at an average price of $49.69, for a total transaction of $1,368,462.60.
• On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The shares were sold at an average price of $50.60, for a total transaction of $297,325.60.

Heartflow Stock Up 2.6%

Shares of NASDAQ HTFL opened at $49.57 on Friday. The firm has a market cap of $4.31 billion and a P/E ratio of -27.09. Heartflow, Inc. has a twelve month low of $20.13 and a twelve month high of $51.78. The company has a 50 day moving average of $37.27 and a 200 day moving average of $31.57.

Heartflow (NASDAQ:HTFL) last issued its earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The business had revenue of $64.08 million for the quarter. The company’s revenue for the quarter was up 47.7% on a year-over-year basis. As a group, equities analysts expect that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

Institutional Trading of Heartflow

Several institutional investors and hedge funds have recently added to or reduced their stakes in HTFL. XXEC Inc. purchased a new stake in Heartflow during the 2nd quarter valued at approximately $2,524,764,000. BlackRock Inc. bought a new position in shares of Heartflow during the second quarter worth $152,502,000. Bamco Inc. NY purchased a new position in Heartflow during the second quarter valued at $94,625,000. Jupiter Topco LLC purchased a new position in Heartflow during the second quarter valued at $70,983,000. Finally, Janus Henderson Group PLC lifted its stake in Heartflow by 152.0% in the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock worth $53,063,000 after purchasing an additional 1,315,416 shares in the last quarter.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. Benchmark reiterated a “buy” rating on shares of Heartflow in a research note on Friday, August 14th. Freedom Capital upgraded shares of Heartflow to a “strong-buy” rating in a research report on Tuesday, June 30th. Morgan Stanley upped their target price on shares of Heartflow from $35.00 to $40.00 and gave the company an “equal weight” rating in a report on Friday, August 14th. JPMorgan Chase & Co. lifted their price target on shares of Heartflow from $35.00 to $45.00 and gave the stock an “overweight” rating in a research note on Friday, August 14th. Finally, Stifel Nicolaus boosted their price objective on shares of Heartflow from $40.00 to $45.00 and gave the company a “buy” rating in a research report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Heartflow presently has an average rating of “Moderate Buy” and a consensus price target of $44.88.

Heartflow Company Profile

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries.

The company’s primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).